Pacific Biosciences Of California Total Liabilities 2010-2023 | PACB

Pacific Biosciences Of California total liabilities from 2010 to 2023. Total liabilities can be defined as the total value of all possible claims against the corporation.
Pacific Biosciences Of California Annual Total Liabilities
(Millions of US $)
2023 $1,045
2022 $1,204
2021 $1,216
2020 $78
2019 $93
2018 $56
2017 $58
2016 $53
2015 $58
2014 $69
2013 $67
2012 $20
2011 $27
2010 $26
2009 $9
Pacific Biosciences Of California Quarterly Total Liabilities
(Millions of US $)
2023-12-31 $1,045
2023-09-30 $1,135
2023-06-30 $1,206
2023-03-31 $1,204
2022-12-31 $1,204
2022-09-30 $1,192
2022-06-30 $1,194
2022-03-31 $1,202
2021-12-31 $1,216
2021-09-30 $1,193
2021-06-30 $988
2021-03-31 $972
2020-12-31 $78
2020-09-30 $171
2020-06-30 $172
2020-03-31 $174
2019-12-31 $93
2019-09-30 $95
2019-06-30 $95
2019-03-31 $91
2018-12-31 $56
2018-09-30 $51
2018-06-30 $52
2018-03-31 $54
2017-12-31 $58
2017-09-30 $56
2017-06-30 $62
2017-03-31 $66
2016-12-31 $53
2016-09-30 $52
2016-06-30 $53
2016-03-31 $51
2015-12-31 $58
2015-09-30 $58
2015-06-30 $63
2015-03-31 $66
2014-12-31 $69
2014-09-30 $69
2014-06-30 $69
2014-03-31 $66
2013-12-31 $67
2013-09-30 $69
2013-06-30 $34
2013-03-31 $33
2012-12-31 $20
2012-09-30 $20
2012-06-30 $22
2012-03-31 $27
2011-12-31 $27
2011-09-30 $27
2011-06-30 $28
2011-03-31 $30
2010-12-31 $26
2010-09-30 $28
2010-06-30 $0
2010-03-31 $0
2009-12-31
2009-09-30 $0
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.364B $0.201B
Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $220.398B 26.71
Intuitive Surgical (ISRG) United States $133.018B 80.13
DexCom (DXCM) United States $54.600B 91.31
Edwards Lifesciences (EW) United States $53.337B 35.30
IQVIA Holdings (IQV) United States $43.712B 25.92
IDEXX Laboratories (IDXX) United States $41.050B 49.08
Alcon (ALC) Switzerland $39.236B 28.93
STERIS (STE) Ireland $20.039B 23.72
Waters (WAT) United States $18.401B 26.40
Hologic (HOLX) United States $18.006B 19.87
SONOVA HOLDING (SONVY) Switzerland $16.668B 0.00
ShockWave Medical (SWAV) United States $12.299B 84.98
Fresenius Medical Care AG KGaA (FMS) Germany $12.183B 15.04
Sysmex ADR (SSMXY) Japan $10.136B 31.79
Teleflex (TFX) United States $9.946B 15.62
Penumbra (PEN) United States $7.979B 98.64
Masimo (MASI) United States $7.192B 40.33
Globus Medical (GMED) United States $6.964B 22.08
Glaukos (GKOS) United States $5.066B 0.00
Integer Holdings (ITGR) United States $4.130B 26.40
LivaNova (LIVN) United Kingdom $3.018B 19.91
TransMedics (TMDX) United States $2.908B 0.00
PROCEPT BioRobotics (PRCT) United States $2.697B 0.00
Elekta AB (EKTAY) Sweden $2.654B 18.21
Nihon Kohden (NHNKY) Japan $2.411B 20.40
Integra LifeSciences Holdings (IART) United States $2.309B 9.48
Tandem Diabetes Care (TNDM) United States $2.267B 0.00
Inari Medical (NARI) United States $2.213B 381.80
RxSight (RXST) United States $1.954B 0.00
Alphatec Holdings (ATEC) United States $1.758B 0.00
Veracyte (VCYT) United States $1.494B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.864B 15.99
Artivion (AORT) United States $0.862B 99.62
OPKO Health (OPK) United States $0.857B 0.00
Paragon 28 (FNA) United States $0.799B 0.00
OrthoPediatrics (KIDS) United States $0.742B 0.00
Silk Road Medical (SILK) United States $0.688B 0.00
Treace Medical Concepts (TMCI) United States $0.659B 0.00
SiBone (SIBN) United States $0.619B 0.00
Mesa Laboratories (MLAB) United States $0.564B 19.13
IRadimed (IRMD) United States $0.537B 31.21
ORTHOFIX MEDICAL INC (OFIX) United States $0.507B 0.00
Nevro (NVRO) United States $0.459B 0.00
NeuroPace (NPCE) United States $0.389B 0.00
Pulse Biosciences (PLSE) United States $0.379B 0.00
Tactile Systems Technology (TCMD) United States $0.357B 12.03
CVRx (CVRX) United States $0.311B 0.00
AxoGen (AXGN) United States $0.300B 0.00
Sight Sciences (SGHT) United States $0.278B 0.00
EDAP TMS S.A (EDAP) France $0.254B 0.00
AngioDynamics (ANGO) United States $0.235B 0.00
Accuray (ARAY) United States $0.218B 0.00
Atossa Genetics (ATOS) United States $0.188B 0.00
Semler Scientific (SMLR) United States $0.187B 10.08
908 Devices (MASS) United States $0.185B 0.00
Alpha Tau Medical (DRTS) Israel $0.173B 0.00
Inogen (INGN) United States $0.166B 0.00
ClearPoint Neuro (CLPT) United States $0.144B 0.00
Delcath Systems (DCTH) United States $0.139B 0.00
Neuronetics (STIM) United States $0.112B 0.00
Yubo Biotech (YBGJ) China $0.112B 0.00
KORU Medical Systems (KRMD) United States $0.101B 0.00
Envoy Medical (COCH) United States $0.098B 0.00
Spectral Diagnostics (EDTXF) Canada $0.086B 0.00
Monogram Orthopaedics (MGRM) United States $0.074B 0.00
EnVVeno Medical (NVNO) United States $0.070B 0.00
SEP Acquisition (SEPA) United States $0.059B 0.00
Autonomix Medical (AMIX) United States $0.059B 0.00
Hyperfine (HYPR) United States $0.058B 0.00
Sensus Healthcare (SRTS) United States $0.054B 109.33
Vasomedical (VASO) United States $0.050B 9.00
Vicarious Surgical (RBOT) United States $0.048B 0.00
DarioHealth (DRIO) United States $0.045B 0.00
InspireMD (NSPR) Israel $0.043B 0.00
Aspira Women's Health (AWH) United States $0.042B 0.00
ReWalk Robotics (LFWD) Israel $0.040B 0.00
Rapid Micro Biosystems (RPID) United States $0.040B 0.00
Pixie Dust Technologies (PXDT) Japan $0.038B 0.00
LENSAR (LNSR) United States $0.037B 0.00
Precision Optics (POCI) United States $0.034B 0.00
Lucid Diagnostics (LUCD) United States $0.033B 0.00
Spectral AI (MDAI) United States $0.032B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.024B 0.00
Ekso Bionics Holdings (EKSO) United States $0.021B 0.00
Accelerate Diagnostics (AXDX) United States $0.020B 0.00
QT Imaging Holdings (QTI) United States $0.019B 0.00
PAVmed (PAVM) United States $0.017B 0.00
T2 Biosystems (TTOO) United States $0.015B 0.00
Biosig Technologies (BSGM) United States $0.015B 0.00
NexGel (NXGL) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
Microbot Medical (MBOT) United States $0.013B 0.00
Avinger (AVGR) United States $0.006B 0.00
Venus Concept (VERO) Canada $0.005B 0.00
Helius Medical Technologies (HSDT) United States $0.004B 0.00
Dynatronics (DYNT) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00